LCTX — LINEAGE CELL THERAPEUTICS IN

Ownership history in Point72 (DIFC) Ltd  ·  1 quarter on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in LINEAGE CELL THERAPEUTICS IN (LCTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 INITIATED 11,400 — — 0.00% $10K $0.91
% of Fund (quarterly)    LCTX price (monthly, adj. close)

Other funds also holding LCTX

As of 2025 Q4 — sorted by position size

RAFFLES ASSOCIATES LP 3Y 7Y 6.72% BROADWOOD CAPITAL INC 3Y 7Y 4.86% Defender Capital, LLC. 3Y 3.7% Informed Momentum Co LLC 3Y 7Y 0.08% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.05% Catalyst Funds Management Pty Ltd 0.02% Beirne Wealth Consulting Services, LLC 3Y 7Y 0.02% ELCO Management Co., LLC 3Y 7Y 0.02% STONERIDGE INVESTMENT PARTNERS LLC 3Y 7Y 0.01% Piscataqua Savings Bank 3Y 0.01%
← Back to Point72 (DIFC) Ltd Holdings